The partnership, called the Bridge Project, will be supported with $2.6 million over two years. Project leaders aim to raise $50 million over the next three to five years to further support research on pancreatic cancer, glioblastoma and other cancers.
The project will allow clinicians and scientists from DF/HCC and scientists and engineers from the Koch Institute to learn from each other and gain new perspectives on their work. The organizations will join clinical knowledge with technology to develop new treatments. For example, DF/HCC and the Koch Institute are studying how a new technology called “nanowell” could be used to study individual cells in glioblastoma. The scientists are also working on a new stent to release chemotherapy for pancreatic cancer.
More Articles on Hospital Oncology:
Verde Valley Medical Center Affiliates With The University of Arizona Cancer Center
University Hospital Offers New Pain Relief Treatment to Cancer Patients
Johns Hopkins Kimmel Cancer Center Offers Young Adult Patient Navigation Program
